By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioTime and its wholly owned subsidiary LifeMap Sciences announced today it is acquiring XenneX for an undisclosed amount.

XenneX will be merged into LifeMap. The deal is expected to close in 30 days.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.